technologyreview.com · 5 min
AI models need more data about biology, and OpenAI is paying to create itOpenAI is funding the creation of a dataset of biotech regulatory filings and safety data from bankrupt companies. The goal is to train AI models that can help demystify the drug approval process, which is notoriously opaque.



